Improving renal transplant outcomes in African Americans with OKT3 induction therapy.
Light
J A
JA
Transplantation Services, Washington Hospital Center, Washington, DC 20010.
Kelly
J L
JL
Aquino
A
A
Neu
L
L
DeNavas
L
L
Williams
K
K
D000328:Adult; D001741:Black or African American; D044383:Black People; D003928:Diabetic Nephropathies / Q000601:surgery; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012086:Reoperation; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D044465:White People
D016853:Muromonab-CD3